CSS
MED icon

Cubist Systematic Strategies’s Medifast MED Stock Holding History

Cubist Systematic Strategies’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,600
Closed -$253K – 3297
2024
Q2 		$253K Sell
11,600
-5,200
-31% -$139K ﹤0.01% 2421
2024
Q1 		$644K Buy
+16,800
New +$814K ﹤0.01% 2465

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's MED Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Medifast (MED) in Q4 2023, closing a stake of 39,911 shares — an estimated $2.99M sold.

Cubist Systematic Strategies first reported a position in MED in Q4 2017 and held it in 24 quarters. The position peaked at $11.7M in Q1 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 39,911 Medifast shares in Q4 2023, an estimated $2.99M.
  • Cubist Systematic Strategies first reported a position in Medifast in Q4 2017 and held it in 24 quarters.
  • Cubist Systematic Strategies's Medifast position peaked at $11.7M in Q1 2023.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.